Format

Send to

Choose Destination
Reprod Toxicol. 2007 Nov-Dec;24(3-4):414-6. Epub 2007 Jul 7.

Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy.

Author information

1
Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. pablolabarga@gmail.com

Erratum in

  • Reprod Toxicol. 2008 Nov-Dec;26(3-4):310. del Prado, Yolanda Ruiz [corrected to Ruiz, Yolanda].

Abstract

The product label of ribavirin states that it is contraindicated during pregnancy, so the risk in its administering during pregnancy is concerned. We show a case of an infant of 22 months of age with no anomalies born from an HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy. The infant is neither HIV- nor HCV-infected.

PMID:
17698320
DOI:
10.1016/j.reprotox.2007.07.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center